Showing results (1151-1160 of 1,458) with videos related to

Sort By:
Pageof 146
Molecular Cancer Therapeutics|March 21, 2013
RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparibAhrum Min, Seock-Ah Im, Young-Kwang Yoon, et al.
Breast Cancer Research and Treatment|January 24, 2019
Prognostic effects of abnormal DNA damage response protein expression in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Nature|March 23, 2012
Structure of the human κ-opioid receptor in complex with JDTicHuixian Wu, Daniel Wacker, Mauro Mileni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with SorafenibDae-Won Lee, Eun Ju Cho, Jeong-Hoon Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2023
Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerizationLucy C Young, Ruby Goldstein de Salazar, Sae-Won Han, et al.
Digestive Diseases and Sciences|April 15, 2019
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis BHae Lim Lee, Jeong Won Jang, Ji Won Han, et al.
Oncology Letters|July 5, 2024
Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinomaJi Hoon Kim, Young Hoon Kim, Hee-Chul Nam, et al.
Oncotarget|August 13, 2016
Therapeutic implication of HER2 in advanced biliary tract cancerAh-Rong Nam, Ji-Won Kim, Yongjun Cha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 3, 2019
Peripheral blood transcriptome analysis and development of classification model for diagnosing antibody-mediated rejection vs accommodation in ABO-incompatible kidney transplantHee Jung Jeon, Jae-Ghi Lee, Kwangsoo Kim, et al.
Journal of Medicinal Chemistry|August 17, 2022
GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine ReceptorAnna Shiriaeva, Daejin Park, Gyudong Kim, et al.
Pageof 146